or T y 3 rather than a primary neoplastic process.
In contrast to the cases previously reported, our case showed a leukemic expansion of LGLs, which were found to be associated with a considerable NK cell activity and have a unique Leu-1 I + , LGLs (Fig 2A and B) .
NK cell activity. Figure  3 shows NK cell activities in the patient's
LGLs LGLs. LGLs from blood and lymphoid tissues using HNK-1 (Leu-7) and Leu-l I monoclonal antibodies. Each subpopulation (HNK-l + Leu-l I -, HNK-l + Leu-1 I +, and HNK-I -Leu-l I +) had a different NK cell activity. Among these three subsets, the HNK-l + subset lacking the Leu-1 I appeared to be the most immature form of LGLs and had minimal NK cell activity, whereas the HNK-l -Leu-1 I + 
CFU-C assay.

